STOCK TITAN

Totaligent (TGNT) Stock News

TGNT OTC

Welcome to our dedicated page for Totaligent news (Ticker: TGNT), a resource for investors and traders seeking the latest updates and insights on Totaligent stock.

Totaligent Inc. provides intelligent business marketing, AI-powered data solutions and digital communications infrastructure as an OTC issuer. Company news covers its omni-channel marketing platform, client onboarding automation, engineering processes, product development and strategic expansion into medical-platform and biologics-related services.

Recurring updates include digital marketing platform launches, infrastructure improvements, executive and board appointments, strategic agreements, medical-tourism initiatives and evaluation of prior crypto-mining activities. Totaligent's news profile combines marketing technology, data-driven communications and newer healthcare-adjacent platform initiatives.

Rhea-AI Summary

Totaligent (OTCID: TGNT) closed its strategic acqui-hire of the Aetherium Medical platform and team, completing its entry into high-growth biologics and Asia-Pacific medical-tourism markets.

The deal transfers Aetherium’s proprietary assets into new subsidiary Aetherium Med One, and appoints founder Ivan Klarich as President and Board member.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
none
-
Rhea-AI Summary

Totaligent (OTCID: TGNT) executed a Definitive Agreement to acqui-hire the Aetherium Medical platform and team led by Ivan Klarich, who will be appointed President and join the board. Totaligent will form a wholly owned subsidiary, Aetherium Medical LLC, and receive Aetherium's proprietary assets for milestone-based equity.

The agreement contemplates an initial 10% fully-diluted equity issuance upon Closing, additional milestone issuances, and potential integration into a separate joint venture with GloMed Solutions; Closing is expected in approximately 30 days, subject to customary conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.36%
Tags
none
-
Rhea-AI Summary

Totaligent (OTCID: TGNT) executed a binding LOI with GloMed on Feb 22, 2026 to form a joint venture integrating the Aetherium Medical platform into GloMed's Japanese medical aesthetics and biologics distribution operations.

The JV will be contribution-based with no initial cash, a three-member board giving Totaligent strategic control, and a binding one-year call option for Totaligent to acquire 100% of GloMed; close targeted ~March 22, 2026, subject to due diligence and a PCAOB-compliant audit.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.52%
Tags
partnership acquisition
Rhea-AI Summary

Totaligent (OTCID: TGNT) executed a binding LOI on Feb 11, 2026 to acqui-hire Aetherium Medical's team, IP, platform assets and business plan via a non-cash asset contribution.

Totaligent will form Aetherium Medical LLC, grant 10% restricted preferred stock to Aetherium team at closing, and targets close around early March 2026, subject to due diligence, definitive agreements, and approvals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.43%
Tags
none
-
Rhea-AI Summary

Totaligent (OTCID: TGNT) said on December 30, 2025 it is evaluating a potential relaunch of previously operated crypto mining activities as part of its 2026 strategic initiatives. The company completed QA testing across key Totaligent platform components (Smart Capture, Display Ads, Analytics, Pulse, campaign tools) and is reviewing technology roadmap, scalability, and AI applications for data enrichment and campaign optimization.

Totaligent cited prior GPU-based Ethereum mining experience and said the review is phase-based, will consider market, hardware, financial, regulatory (including the GENIUS Act) and compliance factors, and that no decisions or timelines have been finalized. The company also said potential mining activity would be weighed alongside capital markets plans, including a possible uplisting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.66%
Tags
crypto
-
Rhea-AI Summary

Totaligent (OTCID: TGNT) announced completion of quality assurance testing across its full marketing and campaign platform on Dec 23, 2025, making all core modules fully tested, validated, and operational.

The unified platform includes Smart Capture (visitor intelligence), Totaligent Ads (display advertising with fraud prevention), Analytics & Reporting, Pulse (media intelligence), content management tools, and social integrations with Meta, X, and LinkedIn. Management said the milestone positions the company to prioritize AI enhancements, customer adoption, revenue growth, and strategic expansion in 2026.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.02%
Tags
none
Rhea-AI Summary

Totaligent (OTCID: TGNT) announced on October 23, 2025 that it is preparing for the commercial launch of an all-in-one, AI-powered omni-channel marketing platform now in closed beta. The platform consolidates Programmatic Advertising, Social-media, Email ESP, SMS, and Push Notifications into a single interface and claims to remove the need for external APIs or plug-ins such as Twilio, SendGrid, or SES.

The system uses a GPU-accelerated database powered by NVIDIA for real-time attribution, channel-specific engagement tracking, and advanced audience creation after two years of ground-up development.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
32.35%
Tags
none
-
Rhea-AI Summary

Totaligent (OTCID: TGNT) has announced significant platform upgrades, including a new automated client onboarding system and the successful launch of its core campaign products. The automated onboarding system features domain detection, DNS configuration, and email record setup, reducing client setup time by over 50%.

The company has also completed quality assurance testing for its Email, SMS, and Push Notification modules, which are now fully operational. These developments are part of Totaligent's bi-weekly sprint development process, aimed at modernizing their marketing technology platform and improving service delivery.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.86%
Tags
none
-
Rhea-AI Summary
Totaligent (OTCPK: TGNT) has announced significant developments in its product development strategy, including the onboarding of new technical leadership and implementation of a bi-weekly sprint process. The company has hired a Lead Backend Developer and Full-Stack Developer to enhance its business intelligence platform. Key improvements include fixing SMS and email campaign delivery issues, modernizing UI/UX with a refreshed login experience and dashboard redesign, and completing a thorough analysis of system architecture. Under President Nicolas Caridi's leadership, Totaligent's upcoming 30-day roadmap focuses on enhancing user experience, platform stability, and establishing a scalable solution. Future plans include implementing a modernized site design, ensuring demo-readiness, strengthening engineering autonomy, and developing an AI-integrated product roadmap.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.57%
Tags
none
Rhea-AI Summary

Totaligent (OTCPK: TGNT) has announced three key appointments to strengthen its leadership and engineering teams. Nicolas Caridi joins as President, bringing experience in scaling startups, having previously led an AI healthcare venture to $1M in ARR within a year. Matthew Tristan becomes Director of Engineering, bringing blockchain expertise from his work on USDM on Cardano blockchain ($11M in assets). Ullas Mahalingappa joins as Front-End Software Developer with a decade of experience in finance, healthcare, and cloud services.

These strategic hires aim to accelerate the development of Totaligent's AI-powered marketing platform, which combines artificial intelligence, blockchain innovation, and full-stack development for person-based marketing solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.67%
Tags
AI

FAQ

What is the current stock price of Totaligent (TGNT)?

The current stock price of Totaligent (TGNT) is $0.019 as of May 22, 2026.

What is the market cap of Totaligent (TGNT)?

The market cap of Totaligent (TGNT) is approximately 6.9M.